UNSPSC 51285908: Pirtenidine

This classification denotes a topical anti-infective agent with the molecular formula C21H38N2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier S6ON6743TM, chemically known as 1,4-dihydro-1-octyl-4-(octylimino)pyridine but more generally known as pirtenidine, which bears US NIH Compound Identifier 65879. European Medicines Agency schedules Pirtenidine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09944MIG.

The term PIRTENIDINE is an International Non-Proprietary Name or INN (see World Health Organization INN reference publication, Volume 1, No. 4, 1987, List 27). PIRTENIDINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. SMILES: N1(CCCCCCCC)CC/C(=N/CCCCCCCC)CC1.

UNSPSC 51285908 Pirtenidine is a Commodity code that covers specialized pharmaceutical products procured by state and local health agencies, though the recent opportunities block shows little direct activity under this specific code. The two most recent state and local records tagged to this code involve pharmaceutical procurement — an Illinois Department of Public Health piggyback award through MMCAP Infuse to Chartwell Rx LLC for antibiotic tablets (Doxycycline Hyclate and Ciprofloxacin Hydrochloride), and a Seminole County, Florida IFB for Naloxone and drug deactivation systems — neither of which appears to be pirtenidine itself. State and local procurement under this code appears to flow through state departments of health and county health agencies using cooperative purchasing vehicles (MMCAP Infuse, for example) and traditional competitive bidding processes.

Geographic activity in the recent record is sparse and shows only Illinois and Florida. The Illinois Department of Public Health awarded a $2,999,999.11 contract to Chartwell Rx LLC on an IFB basis with a 12-month initial term and two one-year renewal options posted August 28, 2026 with a response date of September 11, 2026. Seminole County released an IFB on June 30, 2026 for quarterly delivery of health-related pharmaceutical supplies with a response deadline of July 26, 2026. The code shows limited recent solicitation velocity; the source provides no other representative opportunities and no evidence of active open opportunities seeking pirtenidine specifically. Business development professionals should verify whether pirtenidine is actually being sought under this code or whether recent tagging reflects miscoding of related pharmaceutical categories.